977
Views
4
CrossRef citations to date
0
Altmetric
Clinical Study

Significance of mast cell renal infiltration in patients with anti-GBM nephritis

, , , , , & show all
Pages 906-913 | Received 21 Dec 2015, Accepted 25 Feb 2016, Published online: 20 Apr 2016

References

  • Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol. 1989;7:59–76.
  • Blank U, Essig M, Scandiuzzi L, Benhamou M, Kanamaru Y. Mast cells and inflammatory kidney disease. Immunol Rev. 2007;217:79–95.
  • Armbrust T, Batusic D, Ringe B, Ramadori G. Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol. 1997;26:1042–1054.
  • Roberts IS, Brenchley PE. Mast cells: The forgotten cells of renal fibrosis. J Clin Pathol. 2000;53:858–862.
  • Holdsworth SR, Allen DE, Thomson NM, Glasgow EF, Atkins RC. Histochemistry of glomerular cells in animal models of crescentic glomerulonephritis. Pathology. 1980;12:339–346.
  • Zheng JM, Yao GH, Cheng Z, et al. Pathogenic role of mast cells in the development of diabetic nephropathy: A study of patients at different stages of the disease. Diabetologia. 2012;55:801–811.
  • Tóth T, Tóth-Jakatics R, Jimi S, Ihara M, Urata H, Takebayashi S. Mast cells in rapidly progressive glomerulonephritis. J Am Soc Nephrol. 1999;10:1498–1505.
  • Timoshanko JR, Kitching AR, Semple TJ, Tipping PG, Holdsworth SR. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2006;17:150–159.
  • Hochegger K, Siebenhaar F, Vielhauer V, et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur J Immunol. 2005;35:3074–3082.
  • Kanamaru Y, Scandiuzzi L, Essig M, et al. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J Immunol. 2006;176:5607–5615.
  • Cui Z, Zhao MH, Xin G, Wang HY. Characteristics and prognosis of Chinese patients with antiglomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49–c55.
  • Kondo S, Kagami S, Kido H, Strutz F, Müller GA, Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol. 2001;12:1668–1676.
  • Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgioioso G, Bertoli S, D’Amico G. The detection of monocytes in human glomerulonephritis. Kidney Int. 1985;28:513–519.
  • Tang Z, Wu Y, Hu W, et al. The distribution and significance of renal infiltrating cells in patients with diffuse crescentic glomerulonephritis. Chin Med J (Engl). 2001;114:1267–1269.
  • Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–1636.
  • Daly C, Conlon PJ, Medwar W, Walshe JJ. Characteristics and outcome of anti-glomerular basement membrane disease: A single-center experience. Ren Fail. 1996;18:105–112.
  • Levy JB, Turner AN, Rees AJ, Pusey CD. Long term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033–1042.
  • Jindal KK. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations. Kidney Int Suppl. 1999;70:S33–S40.
  • Kitching AR, Holdsworth SR, Tipping PG. Crescentic glomerulonephritis – A manifestation of a nephritogenic Th1 response? Histol Histopathol. 2000;15:993–1003.
  • El Nahas AM. Glomerulosclerosis: Intrinsic and extrinsic pathways. Nephrol Dial Transplant. 1996;11:773–777.
  • Holdsworth SR, Summers SA. Role of mast cells in progressive renal diseases. J Am Soc Nephrol. 2008;19:2254–2261.
  • El-Koraie AF, Baddour NM, Adam AG, El Kashef EH, El Nahas AM. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides. Kidney Int. 2001;60:167–172.
  • Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin–angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251–287.
  • Mackins CJ, Kano S, Seyedi N, et al. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest. 2006;116:1063–1070.
  • Jones SE, Kelly DJ, Cox AJ, Zhang Y, Gow RM, Gilbert RE. Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int. 2003;64:906–913.
  • Silver RB, Reid AC, Mackins CJ, et al. Mast cells: A unique source of renin. Proc Natl Acad Sci USA. 2004;101:13607–13612.
  • Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75:1145–1152.
  • Atkins RC. Macrophages in renal injury. Am J Kidney Dis. 1998;31:xlv–xlvii.
  • Bulfone-Paus S, Bahri R. Mast cells as regulators of T cell responses. Front Immunol. 2015;6:394.
  • Villa I, Skokos D, Tkaczyk C, et al. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology. 2001;102:165–172.
  • Tanda S, Mori Y, Kimura T, et al. Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats. Kidney Int. 2007;72:608–613.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.